institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

NHS Makes Weight Loss Jab Guidance Change Including Wegovy and Mounjaro - 'It's Crucial'

UNITED KINGDOM, AUG 5 – NHS guidance calls for at least one year of monitoring and support after weight-loss drug treatment to prevent weight regain, affecting about 240,000 patients with greatest need.

  • Health chiefs in the UK raised concerns in 2025 that patients often regain weight after stopping weight-loss drugs like Wegovy and Mounjaro.
  • These concerns stem from research and reports highlighting the lack of structured advice and follow-up support after treatment ends, especially for NHS patients.
  • The NHS currently provides these medications through specialist clinics to a limited number of patients, while most people pay privately and do not receive NHS aftercare.
  • Nice's new quality standard mandates at least a year of monitoring and extra support after treatment, emphasizing long-term lifestyle changes and continuity of care.
  • This approach aims to help patients sustain weight management success over time, recognizing weight loss as a long-term journey requiring ongoing support.
Insights by Ground AI
Does this summary seem wrong?

17 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 45% of the sources lean Left
45% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Daily News Update broke the news in on Monday, August 4, 2025.
Sources are mostly out of (0)